Lobectomy Versus Stereotactic Body Radiotherapy in Healthy Octogenarians With Stage I Lung Cancer

医学 肺癌 阶段(地层学) 危险系数 倾向得分匹配 比例危险模型 置信区间 全肺切除术 多元分析 生存分析 放射治疗 放射外科 内科学 肿瘤科 外科 古生物学 生物
作者
Syed S. Razi,Karishma Kodia,Ahmed Alnajar,Mark I. Block,Francisco Tarrazzi,Dao M. Nguyen,Nestor Villamizar
出处
期刊:The Annals of Thoracic Surgery [Elsevier BV]
卷期号:111 (5): 1659-1665 被引量:22
标识
DOI:10.1016/j.athoracsur.2020.06.097
摘要

BackgroundStereotactic body radiation therapy (SBRT) is increasingly being offered for early stage non-small cell lung cancer (NSCLC). We sought to evaluate long-term survival outcomes after lobectomy and SBRT in patients aged 80 years or more with stage I NSCLC.MethodsThe National Cancer Database was queried for patients with clinical stage IA and IB (size 40 mm or smaller) NSCLC who underwent SBRT or lobectomy. Only patients with no comorbidities were selected. Number of lymph nodes (LN) examined was used to stratify lobectomy patients into 0 LN, 1 to 6 LN, and 7 or more LN. Propensity score analysis was used to adjust treatment groups. Kaplan-Meier and multivariate Cox regression analysis were used for survival analysis.ResultsA total of 8964 patients with stage I NSCLC treated with lobectomy were compared with 286 patients who received SBRT. Using propensity matched pairs, lobectomy (7 LN or more) had significantly improved survival as compared with SBRT (median 74 vs 53.2 months, P < .05); however, no survival differences were observed when 0 LN were sampled (median 53.8 vs 52.3 months, P = .88). In multivariate analysis, lobectomy was associated with significantly improved survival (hazard ratio 0.726; 95% confidence interval; 0.580 to 0.910; P = .005). In addition, age, sex, high grade, and tumor size were independent predictors of survival.ConclusionsAmong healthy octogenarians with clinical stage I NSCLC who are good surgical candidates, lobectomy offers better survival than SBRT. Adequate LN dissection allows true nodal staging and opportunity for adjuvant treatment when unsuspected nodal metastases are found. Stereotactic body radiation therapy (SBRT) is increasingly being offered for early stage non-small cell lung cancer (NSCLC). We sought to evaluate long-term survival outcomes after lobectomy and SBRT in patients aged 80 years or more with stage I NSCLC. The National Cancer Database was queried for patients with clinical stage IA and IB (size 40 mm or smaller) NSCLC who underwent SBRT or lobectomy. Only patients with no comorbidities were selected. Number of lymph nodes (LN) examined was used to stratify lobectomy patients into 0 LN, 1 to 6 LN, and 7 or more LN. Propensity score analysis was used to adjust treatment groups. Kaplan-Meier and multivariate Cox regression analysis were used for survival analysis. A total of 8964 patients with stage I NSCLC treated with lobectomy were compared with 286 patients who received SBRT. Using propensity matched pairs, lobectomy (7 LN or more) had significantly improved survival as compared with SBRT (median 74 vs 53.2 months, P < .05); however, no survival differences were observed when 0 LN were sampled (median 53.8 vs 52.3 months, P = .88). In multivariate analysis, lobectomy was associated with significantly improved survival (hazard ratio 0.726; 95% confidence interval; 0.580 to 0.910; P = .005). In addition, age, sex, high grade, and tumor size were independent predictors of survival. Among healthy octogenarians with clinical stage I NSCLC who are good surgical candidates, lobectomy offers better survival than SBRT. Adequate LN dissection allows true nodal staging and opportunity for adjuvant treatment when unsuspected nodal metastases are found.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YL完成签到,获得积分10
2秒前
NexusExplorer应助小王采纳,获得10
3秒前
3秒前
sl完成签到,获得积分10
3秒前
CC完成签到,获得积分10
4秒前
自信松思完成签到 ,获得积分10
5秒前
荣枫完成签到,获得积分10
5秒前
5秒前
火火火木完成签到 ,获得积分10
6秒前
大模型应助妖孽宇采纳,获得10
6秒前
8秒前
积极行天发布了新的文献求助50
8秒前
受伤凌蝶发布了新的文献求助10
11秒前
fusucheng完成签到,获得积分10
12秒前
koi完成签到,获得积分20
12秒前
12秒前
聪明摩托完成签到,获得积分10
12秒前
阿纯完成签到,获得积分10
13秒前
14秒前
肱二头肌完成签到,获得积分10
15秒前
16秒前
小王发布了新的文献求助10
16秒前
多情自古空余恨完成签到,获得积分10
17秒前
Qionglin完成签到,获得积分10
19秒前
Bao完成签到 ,获得积分10
20秒前
20秒前
初夏微凉发布了新的文献求助30
20秒前
21秒前
书霂完成签到,获得积分10
21秒前
优秀含羞草完成签到,获得积分10
22秒前
宓沂完成签到,获得积分10
22秒前
vivre223完成签到,获得积分10
22秒前
量子星尘发布了新的文献求助10
23秒前
受伤凌蝶完成签到,获得积分10
24秒前
wenjiejiang完成签到,获得积分10
25秒前
25秒前
zly完成签到 ,获得积分10
26秒前
26秒前
李某人完成签到,获得积分10
26秒前
27秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038388
求助须知:如何正确求助?哪些是违规求助? 3576106
关于积分的说明 11374447
捐赠科研通 3305798
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029